B2L11_HUMAN - dbPTM
B2L11_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID B2L11_HUMAN
UniProt AC O43521
Protein Name Bcl-2-like protein 11
Gene Name BCL2L11
Organism Homo sapiens (Human).
Sequence Length 198
Subcellular Localization Endomembrane system
Peripheral membrane protein. Associated with intracytoplasmic membranes..
Isoform BimEL: Mitochondrion. Translocates from microtubules to mitochondria on loss of cell adherence.
Isoform BimL: Mitochondrion.
Isoform BimS:
Protein Description Induces apoptosis and anoikis. Isoform BimL is more potent than isoform BimEL. Isoform Bim-alpha1, isoform Bim-alpha2 and isoform Bim-alpha3 induce apoptosis, although less potent than isoform BimEL, isoform BimL and isoform BimS. Isoform Bim-gamma induces apoptosis. Isoform Bim-alpha3 induces apoptosis possibly through a caspase-mediated pathway. Isoform BimAC and isoform BimABC lack the ability to induce apoptosis..
Protein Sequence MAKQPSDVSSECDREGRQLQPAERPPQLRPGAPTSLQTEPQGNPEGNHGGEGDSCPHGSPQGPLAPPASPGPFATRSPLFIFMRRSSLLSRSSSGYFSFDTDRSPAPMSCDKSTQTPSPPCQAFNHYLSAMASMRQAEPADMRPEIWIAQELRRIGDEFNAYYARRVFLNNYQAAEDHPRMVILRLLRYIVRLVWRMH
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
3Acetylation-----MAKQPSDVSS
-----CCCCCCCCCH
62.5325953088
12S-nitrosylationPSDVSSECDREGRQL
CCCCCHHCCCCCCCC
6.8924105792
34PhosphorylationQLRPGAPTSLQTEPQ
CCCCCCCCCCCCCCC
41.35-
35PhosphorylationLRPGAPTSLQTEPQG
CCCCCCCCCCCCCCC
19.88-
35 (in isoform 9)Phosphorylation-19.88-
35 (in isoform 3)Phosphorylation-19.88-
35 (in isoform 6)Phosphorylation-19.88-
35 (in isoform 7)Phosphorylation-19.88-
38 (in isoform 3)Phosphorylation-55.73-
38PhosphorylationGAPTSLQTEPQGNPE
CCCCCCCCCCCCCCC
55.73-
38 (in isoform 6)Phosphorylation-55.73-
38 (in isoform 7)Phosphorylation-55.73-
38 (in isoform 9)Phosphorylation-55.73-
43 (in isoform 6)Phosphorylation-26.63-
43 (in isoform 7)Phosphorylation-26.63-
43 (in isoform 3)Phosphorylation-26.63-
43 (in isoform 9)Phosphorylation-26.63-
44 (in isoform 5)Phosphorylation-58.6612591950
44 (in isoform 17)Phosphorylation-58.6612591950
44 (in isoform 16)Phosphorylation-58.6612591950
44 (in isoform 15)Phosphorylation-58.6612591950
44 (in isoform 18)Phosphorylation-58.6612591950
44 (in isoform 2)Phosphorylation-58.6612591950
50 (in isoform 12)Phosphorylation-28.3228787133
56 (in isoform 2)Phosphorylation-38.5312591950
58 (in isoform 2)Phosphorylation-26.6012591950
59PhosphorylationGDSCPHGSPQGPLAP
CCCCCCCCCCCCCCC
15.8312818176
60 (in isoform 12)Phosphorylation-47.9822210691
69PhosphorylationGPLAPPASPGPFATR
CCCCCCCCCCCCCCC
35.8417525735
77PhosphorylationPGPFATRSPLFIFMR
CCCCCCCCCEEEEEE
22.9222617229
86PhosphorylationLFIFMRRSSLLSRSS
EEEEEECHHHHCCCC
18.2530266825
87PhosphorylationFIFMRRSSLLSRSSS
EEEEECHHHHCCCCC
31.3623401153
90PhosphorylationMRRSSLLSRSSSGYF
EECHHHHCCCCCCCE
35.1023090842
92PhosphorylationRSSLLSRSSSGYFSF
CHHHHCCCCCCCEEE
26.0229978859
93PhosphorylationSSLLSRSSSGYFSFD
HHHHCCCCCCCEEEC
27.0329978859
94PhosphorylationSLLSRSSSGYFSFDT
HHHCCCCCCCEEECC
38.4717503221
96PhosphorylationLSRSSSGYFSFDTDR
HCCCCCCCEEECCCC
9.6729978859
98PhosphorylationRSSSGYFSFDTDRSP
CCCCCCEEECCCCCC
17.46-
104PhosphorylationFSFDTDRSPAPMSCD
EEECCCCCCCCCCCC
28.3721924351
109PhosphorylationDRSPAPMSCDKSTQT
CCCCCCCCCCCCCCC
20.3623186163
113PhosphorylationAPMSCDKSTQTPSPP
CCCCCCCCCCCCCCC
16.7021712546
114PhosphorylationPMSCDKSTQTPSPPC
CCCCCCCCCCCCCCH
42.0529083192
116PhosphorylationSCDKSTQTPSPPCQA
CCCCCCCCCCCCHHH
26.3122817900
118PhosphorylationDKSTQTPSPPCQAFN
CCCCCCCCCCHHHHH
44.8825849741
127PhosphorylationPCQAFNHYLSAMASM
CHHHHHHHHHHHHHH
11.9429083192
129PhosphorylationQAFNHYLSAMASMRQ
HHHHHHHHHHHHHHH
14.6129083192
133PhosphorylationHYLSAMASMRQAEPA
HHHHHHHHHHHCCCC
11.0429083192
172PhosphorylationRRVFLNNYQAAEDHP
HHHHHHCHHHHCCCH
9.8428796482

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
44SPhosphorylationKinaseCDK1P06493
PSP
44SPhosphorylationKinaseMAPK8P45983
GPS
56TPhosphorylationKinaseMAPK8P45983
GPS
56TPhosphorylationKinaseMAPK9P45984
GPS
58SPhosphorylationKinaseMAPK8P45983
GPS
58SPhosphorylationKinaseMAPK10P53779
GPS
69SPhosphorylationKinaseMAPK1P28482
GPS
69SPhosphorylationKinaseMAPK3P27361
GPS
69SPhosphorylationKinaseMAPK-Uniprot
87SPhosphorylationKinaseAKT1P31749
PSP
87SPhosphorylationKinasePRKACAP17252
GPS
93SPhosphorylationKinaseAURKAO14965
GPS
94SPhosphorylationKinaseAURKAO14965
GPS
98SPhosphorylationKinaseAURKAO14965
GPS
104SPhosphorylationKinaseJNK-SUBFAMILY-GPS
104SPhosphorylationKinaseJNK_GROUP-PhosphoELM
116TPhosphorylationKinaseJNK-SUBFAMILY-GPS
116TPhosphorylationKinaseJNK_GROUP-PhosphoELM
118SPhosphorylationKinaseJNK-SUBFAMILY-GPS
118SPhosphorylationKinaseJNK_GROUP-PhosphoELM
-KUbiquitinationE3 ubiquitin ligaseBTRCQ9Y297
PMID:24658274
-KUbiquitinationE3 ubiquitin ligaseCBLP22681
PMID:18198176
-KUbiquitinationE3 ubiquitin ligaseCISHQ9NSE2
PMID:18420585
-KUbiquitinationE3 ubiquitin ligaseTRIM2Q9C040
PMID:22199232

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
69SPhosphorylation

15486195
69Subiquitylation

15486195

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of B2L11_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
BCL2_HUMANBCL2physical
15694340
B2CL1_HUMANBCL2L1physical
15694340
MCL1_HUMANMCL1physical
15694340
MCL1_HUMANMCL1physical
10837489
VDAC1_RATVdac1physical
12118373
B2CL1_HUMANBCL2L1physical
9430630
B2CL2_HUMANBCL2L2physical
9430630
MCL1_HUMANMCL1physical
9731710
BCL2_HUMANBCL2physical
9731710
B2CL2_HUMANBCL2L2physical
9731710
B2LA1_HUMANBCL2A1physical
9731710
B2CL1_HUMANBCL2L1physical
9731710
BCL2_HUMANBCL2physical
19805519
SNF5_HUMANSMARCB1physical
15096481
GTF2I_HUMANGTF2Iphysical
15096481
TRIM2_RATTrim2physical
21478148
TRIM2_HUMANTRIM2physical
21478148
FBW1A_HUMANBTRCphysical
22388891
CISH_HUMANCISHphysical
19622774
ELOB_HUMANTCEB2physical
19622774
VHL_HUMANVHLphysical
19305426
RACK1_HUMANGNB2L1physical
18420585
CISH_HUMANCISHphysical
18420585
CD302_HUMANCD302physical
18420585
FBW1A_HUMANBTRCphysical
19150432
MCL1_HUMANMCL1physical
19150432
A4_HUMANAPPphysical
21832049
1433B_HUMANYWHABphysical
16282323
FBW1A_HUMANBTRCphysical
23912711
AURKA_HUMANAURKAphysical
23912711
FGL1_HUMANFGL1physical
21988832
RIOK3_HUMANRIOK3physical
21988832
FEM1C_HUMANFEM1Cphysical
21988832
B2CL1_HUMANBCL2L1physical
19427863
F1_VACCWF1Lphysical
17074758
BCL2_HUMANBCL2physical
17074758
MCL1_HUMANMCL1physical
17097560
BCL2_HUMANBCL2physical
17097560
AT2A3_HUMANATP2A3physical
26186194
ANKL2_HUMANANKLE2physical
26186194
MTHR_HUMANMTHFRphysical
26186194
DYL2_HUMANDYNLL2physical
26186194
DYL1_HUMANDYNLL1physical
26186194
FBW1A_HUMANBTRCphysical
26186194
FBW1B_HUMANFBXW11physical
26186194
MCL1_HUMANMCL1physical
26186194
RHPN2_HUMANRHPN2physical
26186194
BAX_HUMANBAXphysical
26186194
BCL2_HUMANBCL2physical
26186194
UBP27_HUMANUSP27Xphysical
27013495
B2CL1_HUMANBCL2L1physical
27013495
MCL1_HUMANMCL1physical
27013495
BCL2_HUMANBCL2physical
20836993
B2CL1_HUMANBCL2L1physical
20836993
MCL1_HUMANMCL1physical
20836993
MK01_HUMANMAPK1physical
24269611
MK03_HUMANMAPK3physical
24269611
MCL1_HUMANMCL1physical
28514442
RHPN2_HUMANRHPN2physical
28514442
MTHR_HUMANMTHFRphysical
28514442
ANKL2_HUMANANKLE2physical
28514442
BCL2_HUMANBCL2physical
28514442
FBW1A_HUMANBTRCphysical
28514442
AT2A3_HUMANATP2A3physical
28514442
FBW1B_HUMANFBXW11physical
28514442
MTA2_HUMANMTA2physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of B2L11_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-77, AND MASSSPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-77, AND MASSSPECTROMETRY.

TOP